Menu
Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing formulation & drug delivery research & development today.
Attendance to our Discussion Groups is available to members of our Formulation & Delivery Member Community. For more information about Membership, please click here.
Taking Place September 2022
Discussion Group Leader:
Martinus Capelle, Scientific Director, Head of Technical Integrator at The Janssen Pharmaceutical Companies of Johnson & Johnson
Discussion Topics:
Protein Aggregation & Solubility Redesign
Vaccine Formulation & Logistics
Stability & Degradation Challenges
Applied Physics: Mixing, Filling and Temperature Calculations
Taking Place October 2022
Discussion Group Leader:
Yamini Shah, Professor at L. M. College of Pharmacy
Discussion Topics:
Developing Powder Formulations – Challenges and Motivation
Particle Morphology: Size and Shape Effects on Delivery
Patient Centricity
Clinical Trials: Challenges
Off-Target Effects
Discussion Group Leader:
Joel Richard, Chief Scientific Officer at Medincell
Discussion Topics:
Reports and write-ups pertaining to previous Discussion Groups are available in our In-Depth section.
June 2022
Discussion Group Leader:
Michael Munson, Senior Research Scientist, Advanced Drug Delivery, AstraZeneca
Discussion Topics:
June 2022
Discussion Group Leader:
Manoj Pal, Principal Scientist, Analytical & Formulation Development
Discussion Group Topics:
April 2022
Discussion Group Leader: Dr. Claudia Krichbaum – Principal Scientist Parenterals at Merck Healthcare
Discussion Topics:
March 2022
Discussion Group Leader: Fausto Artico, Global R&D Tech Head and Director of Innovation and Data Science at GSK
Presentation:
How the manufacturing industry needs to change for continuous manufacturing
Panel Discussion:
March 2022
Discussion Group Leader: Pavan Muttil, Ph.D. Associate Professor, Dept. of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico
Presentation:
A Brief History of Inhalation Devices: Challenges and benefits of different device types
Topics:
November 2021
Biologics-based medicines are an extremely promising avenue for therapeutics. Given their size, they are extremely sensitive once they enter the gastrointestinal system. For the launch of Oxford Global’s first Formulation & Drug Delivery Discussion Group, we are bringing together thought-leaders discussing the oral delivery of biologics; with an in-depth discussion pertaining to their permeability and bioavailability and explore which drugs are fit to be delivered orally emphasizing the importance of knowing the therapeutic area to target.
Presentation: Oral Delivery Of Biologics – Quo Vadis?
Speaker: Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim
Panel Discussion: Oral Delivery of Biologics – Current Challenges & Opportunities
Moderator: Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim
Panellists:
November 2021
The inhalation industry has recently benefitted from renewed interest in the inhaled administration of biologics. The potential for better respiratory and systemic delivery, as well as increased patient comfort, make the inhaled route an attractive proposition to deliver therapies. Our November discussion group brings together an exclusive panel of key opinion leaders discussing the key factors behind the market’s growth, research priorities, future outlook & how to overcome challenges in this exciting area.
Part 1: Presentation: History of Inhaled Biologics
Speaker: David Cipolla, Vice President of Research, Insmed
Part 2: Discussion: Advancing the Development & Delivery of Inhaled Biologics
Moderator:
Carsten Erdhart, Professor in Pharmaceutics and Biopharmaceutics, Trinity College Dublin
Panellists:
Francesca Buttini, Associate Professor, University of Parma
Pavan Muttil, Associate Professor, University of New Mexico
December 2021
What will be the future of innovative drug delivery? How can we improve on our formulation techniques & methods specifically for new modalities? How do we deliver the drugs that truly benefit patients and our society? Join our next discussion group taking a deep dive into exploring the landscape and engage with key opinion leaders for a focused session pertaining to formulating for innovative drug delivery routes.
Topic Areas: Small Molecule Formulation & Delivery – New Modalities, Targeting and Approaches
Discussion Group Leaders:
January 2022
RNA-based therapeutics are cost effective, relatively easy to manufacture, and can target previously undruggable pathways. Join this month’s discussion group to meet key pioneers in the field and explore new ideas for delivering RNA drugs safely and effectively.
Topic Areas
Susan Rosenbaum, Founder, Chairman & Chief Executive Officer of Lauren Sciences LLC
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.